The effect of systemic iron status on osteoarthritis: A mendelian randomization study
Guangfeng Ruan(Guangzhou First People's Hospital), Changhai Ding(Zhujiang Hospital), Peihua Cao(Zhujiang Hospital), Zhaohua Zhu(Royal North Shore Hospital), Shi‐Long Lu(Aviation Industry Corporation of China (China)), Shengfa Li(Third People's Hospital of Chengdu), Yu Liu(Peking University), Tianyu Chen(Third Affiliated Hospital of Southern Medical University), Jia Li(Acceleron Pharma (United States)), Yan Zhang(Nanchang University), Song Xue(Shanxi Medical University), Yanqi Liu(Zhujiang Hospital), Shibo Chen(Helmholtz Zentrum München), Ming Lu(Shandong University), Xiaoshuai Wang(Zhujiang Hospital), Muhui Zeng(Zhujiang Hospital), Yi Ying(Guangzhou First People's Hospital), Jianwei Zhu(University of Iceland)
Cited by 10
Related Papers
Biochar supported nanoscale zerovalent iron composite used as persulfate activator for removing trichloroethylene
|Bioresource Technology|2014|600
Osteoarthritis
|Nature Reviews Disease Primers|2025|316
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations
|Nature Genetics|2014|208
Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy
|Bioactive Materials|2021|203
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
|Genes & Development|2006|201